These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 17853302

  • 1. Levetiracetam in the treatment of antipsychotics-resistant Tourette syndrome.
    Oulis P, Karapoulios E, Masdrakis VG, Kouzoupis AV, Karakatsanis NA, Papageorgiou C, Papadimitriou GN, Soldatos CR.
    World J Biol Psychiatry; 2008; 9(1):76-7. PubMed ID: 17853302
    [Abstract] [Full Text] [Related]

  • 2. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome.
    Hedderick EF, Morris CM, Singer HS.
    Pediatr Neurol; 2009 Jun; 40(6):420-5. PubMed ID: 19433274
    [Abstract] [Full Text] [Related]

  • 3. A double blind randomized placebo control trial of levetiracetam in Tourette syndrome.
    Smith-Hicks CL, Bridges DD, Paynter NP, Singer HS.
    Mov Disord; 2007 Sep 15; 22(12):1764-70. PubMed ID: 17566124
    [Abstract] [Full Text] [Related]

  • 4. Prolactin monitoring of haloperidol and pimozide treatment in children with Tourette's syndrome.
    Sallee FR, Dougherty D, Sethuraman G, Vrindavanam N.
    Biol Psychiatry; 1996 Nov 15; 40(10):1044-50. PubMed ID: 8915564
    [Abstract] [Full Text] [Related]

  • 5. Use of levetiracetam to treat tics in children and adolescents with Tourette syndrome.
    Awaad Y, Michon AM, Minarik S.
    Mov Disord; 2005 Jun 15; 20(6):714-8. PubMed ID: 15704204
    [Abstract] [Full Text] [Related]

  • 6. An open-label, prospective study of levetiracetam in children and adolescents with Tourette syndrome.
    Fernández-Jaén A, Fernández-Mayoralas DM, Muñoz-Jareño N, Calleja-Pérez B.
    Eur J Paediatr Neurol; 2009 Nov 15; 13(6):541-5. PubMed ID: 19211282
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy of haloperidol, pimozide, penfluridol, and clonidine in the treatment of tourette syndrome.
    Shapiro AK, Shapiro E.
    Adv Neurol; 1982 Nov 15; 35():383-6. PubMed ID: 6959514
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of Tourette syndrome].
    Pushkov VV.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986 Nov 15; 86(10):1476-9. PubMed ID: 2880439
    [Abstract] [Full Text] [Related]

  • 9. Levetiracetam in tardive dyskinesia.
    Meco G, Fabrizio E, Epifanio A, Morgante F, Valente M, Vanacore N, Di Rosa AE, Morgante L.
    Clin Neuropharmacol; 2006 Nov 15; 29(5):265-8. PubMed ID: 16960471
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fetal exposure to pimozide: a case report.
    Bjarnason NH, Rode L, Dalhoff K.
    J Reprod Med; 2006 May 15; 51(5):443-4. PubMed ID: 16779996
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacological management of tics in patients with TS.
    Sandor P.
    J Psychosom Res; 2003 Jul 15; 55(1):41-8. PubMed ID: 12842230
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of multiple tics and the Tourette syndrome.
    Gillies DR, Forsythe WI.
    Dev Med Child Neurol; 1984 Dec 15; 26(6):830-3. PubMed ID: 6151532
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.